These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7460192

  • 1. Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.
    Workman P.
    Cancer Chemother Pharmacol; 1980; 5(1):27-37. PubMed ID: 7460192
    [Abstract] [Full Text] [Related]

  • 2. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
    Workman P.
    Br J Cancer; 1979 Sep; 40(3):335-53. PubMed ID: 508562
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA, Workman P.
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
    Brown JM, Yu NY, Workman P.
    Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
    [Abstract] [Full Text] [Related]

  • 5. Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.
    Workman P, White RA.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3041-6. PubMed ID: 6897355
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
    Stratford MR, Minchinton AI, Dische S, Saunders MI, Anderson P.
    Int J Radiat Oncol Biol Phys; 1982 Oct 01; 8(3-4):377-9. PubMed ID: 7107355
    [Abstract] [Full Text] [Related]

  • 8. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
    Williams K, Begg E, Wade D, O'Shea K.
    Clin Pharmacol Ther; 1983 Mar 01; 33(3):314-21. PubMed ID: 6825387
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
    Workman P.
    Cancer Clin Trials; 1980 Mar 01; 3(3):237-51. PubMed ID: 7438321
    [Abstract] [Full Text] [Related]

  • 10. The penetration of misonidazole into spontaneous canine tumours.
    White RA, Workman P, Owen LN, Bleehen NM.
    Br J Cancer; 1979 Aug 01; 40(2):284-94. PubMed ID: 289406
    [Abstract] [Full Text] [Related]

  • 11. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
    Meering PG, Gonzalez DG, Maes RA, van Peperzeel HA.
    Hum Toxicol; 1985 Jul 01; 4(4):425-34. PubMed ID: 4018823
    [Abstract] [Full Text] [Related]

  • 12. Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
    Pedersen JE, Smith MR, Bugden RD, Peckham MJ.
    Br J Cancer; 1979 Apr 01; 39(4):429-33. PubMed ID: 444398
    [Abstract] [Full Text] [Related]

  • 13. The pharmacokinetics of misonidazole in the dog.
    White RA, Workman P, Freedman LS, Owen LN, Bleehen NM.
    Eur J Cancer (1965); 1979 Oct 01; 15(10):1233-42. PubMed ID: 520395
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the O-demethylation of misonidazole by rat liver microsomes.
    Shoemaker DD, McManus ME, Hoerauf R, Strong JM.
    Cancer Treat Rep; 1982 Jun 01; 66(6):1343-7. PubMed ID: 7083238
    [Abstract] [Full Text] [Related]

  • 15. The role of dexamethasone in the modification of misonidazole pharmacokinetics.
    Jones DH, Bleehen NM, Workman P, Walton MI.
    Br J Cancer; 1983 Oct 01; 48(4):553-7. PubMed ID: 6626454
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of misonidazole enantiomers.
    Williams KM.
    Clin Pharmacol Ther; 1984 Dec 01; 36(6):817-23. PubMed ID: 6499361
    [Abstract] [Full Text] [Related]

  • 17. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
    McManus ME, Monks A, Collins JM, White R, Strong JM.
    J Pharmacol Exp Ther; 1981 Dec 01; 219(3):669-74. PubMed ID: 7299690
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G, Canal P, Mockey E, Vandevoorde E, Laurent F, Soula G.
    J Pharmacol; 1983 Dec 01; 14(1):67-77. PubMed ID: 6834852
    [Abstract] [Full Text] [Related]

  • 19. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
    White R, Workman P, Owen L.
    Int J Radiat Oncol Biol Phys; 1982 Dec 01; 8(3-4):473-6. PubMed ID: 7107369
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic considerations of misonidazole in therapeutics.
    Matheson I, Plowman PN, Johnston A.
    Hum Toxicol; 1984 Feb 01; 3(1):29-36. PubMed ID: 6698564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.